Abpro vs Mabqi

Abpro  logo

Abpro

Developing antibody therapies to improve the lives of patients facing severe and life-threatening diseases

39 employees · est. 2007 · Woburn, United States

VS
Mabqi logo

Mabqi

Your key partner for breakthrough antibody discovery

26 employees · est. 2017 · Grabels, France

Abpro is the older company (2007 vs 2017).

Side-by-Side Comparison

Abpro Mabqi
Founded
2007 older 2017
Headquarters
Woburn, United States Grabels, France
Employees
39 26
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology
Funding Stage
Venture round Not tracked yet
Total Funding
$40.39M Not tracked yet
Funding Rounds
3 Not tracked yet
Services
Not tracked yet Discovery and development of fully human antibodies, Antibody Drug Discovery, Antibody Maturation, LiteMab Antibody Discovery Studio services
Target Customers
Not tracked yet Pharmaceutical Companies, Biotechnology Firms, Oncology Researchers, Clinical Research Organizations
Taxonomy
Antibody TherapeuticsImmuno-OncologyOphthalmologyReagentsBiochemistryRecombinant Proteins +8 Antibody DiscoveryFully Human Antibody DiscoveryTherapeutic AntibodiesOncology ApplicationsAntibody Affinity MaturationAntibody Optimization +9
Website
abpro.com mabqi.com
Abpro  logo

About Abpro

Abpro is a biotech company that is dedicated to advancing antibody therapeutics for severe diseases. With a focus on immuno-oncology and ophthalmology, the company leverages its proprietary DiversImmune® and MultiMab platforms to develop next-gen antibodies. Collaborating with global pharmaceutical...

Mabqi logo

About Mabqi

Mabqi, founded in 2017 and headquartered in France, is emerging as a pivotal player in the Biotechnology industry with its cutting-edge approaches to antibody discovery. Under its slogan, "Your key partner for breakthrough antibody discovery," the company leverages proprietary technology, employing...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Abpro and Mabqi for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Abpro or Mabqi moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Abpro was founded in 2007, based in Woburn, United States, with 39 employees. Abpro is a biotech company that is dedicated to advancing antibody therapeutics for severe diseases. With a focus on immuno-oncology and ophthalmology, the company leverages its proprietary DiversImmu. Mabqi was founded in 2017, based in Grabels, France, with 26 employees. Mabqi, founded in 2017 and headquartered in France, is emerging as a pivotal player in the Biotechnology industry with its cutting-edge approaches to antibody discovery. Under its slogan, "Your key pa.
Abpro has raised $40.39M and Mabqi no disclosed funding. Latest stage: Abpro Venture round.
Both work in Biotechnology and list immuno-oncology and therapeutic antibodies among their focus areas.

Compare Abpro with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Abpro on 13 Sep 2024, and Mabqi on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes